Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 06, 2015 5:26 PM ET


Company Overview of Nuron Biotech Inc.

Company Overview

Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was founded in 2010 and is based in Exton, Pennsylvania.

1 East Uwchlan Avenue

Suite 302

Exton, PA 19341

United States

Founded in 2010





Key Executives for Nuron Biotech Inc.

Founder and Director
Founder and Director
Senior Vice President of Research and Development
Vice President of Clinical & Medical Affairs
Vice President of Regulatory Affairs
Compensation as of Fiscal Year 2015.

Nuron Biotech Inc. Key Developments

Nuron Biotech Inc. Presents at 16th Annual BIO CEO & Investor Conference 2014, Feb-10-2014 01:45 PM

Nuron Biotech Inc. Presents at 16th Annual BIO CEO & Investor Conference 2014, Feb-10-2014 01:45 PM. Venue: The Waldorf-Astoria Hotel, Conrad Room, New York, New York, United States.

Nuron Biotech Inc. Announces Executive Appointments

Nuron Biotech Inc. announced the election of Dr. Warren D. Cooper, MB, BS, BSc, MPFM to its Board of Directors in addition to the operational roles of interim President and Chief Executive Officer. Warren was most recently the CEO of Prism Pharmaceuticals. The company also announced the appointment of Dr. Daniel Cushing, Ph.D., FCP to Senior Vice President, Research and Development, and the promotion of Kevin Taylor to Chief Business Officer. Dan will report directly to Warren and is responsible for leading clinical and nonclinical development, medical and regulatory affairs, quality assurance and control, and program management functions. Dan previously worked at Pfizer, Merck, Astra Merck, AstraZeneca and most recently at Prism Pharmaceuticals.

Nuron Biotech Inc. Presents at 19th Annual BIO-Europe International Partnering Conference, Nov-05-2013 08:45 AM

Nuron Biotech Inc. Presents at 19th Annual BIO-Europe International Partnering Conference, Nov-05-2013 08:45 AM. Venue: Messe Wien Exhibition and Congress Center, Vienna, Austria.

Similar Private Companies By Industry

Company Name Region
Univera, Inc. United States
China Yongxin Pharmaceuticals, Inc. United States
Applied Therapeutics, Inc. United States
Therabiol, Inc. United States
Elan Holdings, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nuron Biotech Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at